SGRY vs. OPCH, GH, RDNT, BTSG, SHC, PRVA, CON, LFST, WGS, and VCYT
Should you be buying Surgery Partners stock or one of its competitors? The main competitors of Surgery Partners include Option Care Health (OPCH), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), LifeStance Health Group (LFST), GeneDx (WGS), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.
Surgery Partners vs. Its Competitors
Option Care Health (NASDAQ:OPCH) and Surgery Partners (NASDAQ:SGRY) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, community ranking, dividends, media sentiment, risk, valuation and institutional ownership.
98.1% of Option Care Health shares are held by institutional investors. 0.6% of Option Care Health shares are held by company insiders. Comparatively, 2.3% of Surgery Partners shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
In the previous week, Option Care Health had 1 more articles in the media than Surgery Partners. MarketBeat recorded 6 mentions for Option Care Health and 5 mentions for Surgery Partners. Option Care Health's average media sentiment score of 1.71 beat Surgery Partners' score of 1.20 indicating that Option Care Health is being referred to more favorably in the media.
Option Care Health presently has a consensus price target of $35.50, suggesting a potential upside of 11.55%. Surgery Partners has a consensus price target of $33.56, suggesting a potential upside of 44.46%. Given Surgery Partners' higher possible upside, analysts clearly believe Surgery Partners is more favorable than Option Care Health.
Surgery Partners received 250 more outperform votes than Option Care Health when rated by MarketBeat users. However, 64.00% of users gave Option Care Health an outperform vote while only 57.72% of users gave Surgery Partners an outperform vote.
Option Care Health has higher revenue and earnings than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.
Option Care Health has a beta of 0.74, suggesting that its share price is 26% less volatile than the S&P 500. Comparatively, Surgery Partners has a beta of 1.93, suggesting that its share price is 93% more volatile than the S&P 500.
Option Care Health has a net margin of 4.37% compared to Surgery Partners' net margin of -2.03%. Option Care Health's return on equity of 15.30% beat Surgery Partners' return on equity.
Summary
Option Care Health beats Surgery Partners on 13 of the 17 factors compared between the two stocks.
Get Surgery Partners News Delivered to You Automatically
Sign up to receive the latest news and ratings for SGRY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SGRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Surgery Partners Competitors List
Related Companies and Tools
This page (NASDAQ:SGRY) was last updated on 6/12/2025 by MarketBeat.com Staff
Buy SGRY Stock Free SGRY Stock Alerts